Atlas Trials

Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00363415 · COMPLETED

Trial details

NCT number
NCT00363415
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2006-08-01
Primary completion
2008-06-01
Enrollment
908

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.